Abstract |
The potential in vivo antiviral activity of 3-[bis-(2-hydroxyethyl)-amino]- acetophenone-[4,5- diphenyl-oxazolyl-(2)]- hydrazone ( IMET 98/69) was evaluated on model infections in mice. Animals treated subcutaneously (s.c.) with 1 mmole of the drug per kg body weight once daily for five days were significantly protected against a lethal infection with cardioviruses, Semliki forest virus and vaccinia virus. In influenza A and B virus models no antiviral activity was observed either after s.c. or oral treatment.
|
Authors | A Veckenstedt, M K Indulen, D Dzeguse, I Zgórniak-Nowosielska, I Mécs, I Béládi |
Journal | Acta virologica
(Acta Virol)
Vol. 23
Issue 6
Pg. 500-3
(Nov 1979)
ISSN: 0001-723X [Print] Slovakia |
PMID | 44666
(Publication Type: Journal Article)
|
Chemical References |
- Antiviral Agents
- Oxazoles
- IMET 98-69
|
Topics |
- Administration, Oral
- Animals
- Antiviral Agents
(administration & dosage, therapeutic use)
- Arbovirus Infections
(prevention & control)
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Encephalomyocarditis virus
- Enterovirus Infections
(prevention & control)
- Female
- Injections, Subcutaneous
- Male
- Mice
- Orthomyxoviridae Infections
(prevention & control)
- Oxazoles
(analogs & derivatives, therapeutic use)
- RNA Viruses
- Semliki forest virus
- Vaccinia
(prevention & control)
- Virus Diseases
(prevention & control)
|